Background: We previously derived and validated a bronchial epithelial gene expression biomarker to detect lung cancer in current and former smokers. Given that bronchial and nasal epithelial gene expression are similarly altered by cigarette smoke exposure, we sought to determine if cancer-associated gene expression might also be detectable in the more readily accessible nasal epithelium. Methods: Nasal epithelial brushings were prospectively collected from current and former smokers undergoing diagnostic evaluation for pulmonary lesions suspicious for lung cancer in the AEGIS-1 (n = 375) and AEGIS-2 (n = 130) clinical trials and gene expression profiled using microarrays. All statistical tests were two-sided. Results: We identified 535 genes that were differentially expressed in the nasal epithelium of AEGIS-1 patients diagnosed with lung cancer vs those with benign disease after one year of follow-up ( P < .001). Using bronchial gene expression data from the AEGIS-1 patients, we found statistically significant concordant cancer-associated gene expression alterations between the two airway sites ( P < .001). Differentially expressed genes in the nose were enriched for genes associated with the regulation of apoptosis and immune system signaling. A nasal lung cancer classifier derived in the AEGIS-1 cohort that combined clinical factors (age, smoking status, time since quit, mass size) and nasal gene expression (30 genes) had statistically significantly higher area under the curve (0.81; 95% confidence interval [CI] = 0.74 to 0.89, P = .01) and sensitivity (0.91; 95% CI = 0.81 to 0.97, P = .03) than a clinical-factor only model in independent samples from the AEGIS-2 cohort. Conclusions: These results support that the airway epithelial field of lung cancer-associated injury in ever smokers extends to the nose and demonstrates the potential of using nasal gene expression as a noninvasive biomarker for lung cancer detection.
Background: We previously derived and validated a bronchial epithelial gene expression biomarker to detect lung cancer in current and former smokers. Given that bronchial and nasal epithelial gene expression are similarly altered by cigarette smoke exposure, we sought to determine if cancer-associated gene expression might also be detectable in the more readily accessible nasal epithelium. Methods: Nasal epithelial brushings were prospectively collected from current and former smokers undergoing diagnostic evaluation for pulmonary lesions suspicious for lung cancer in the AEGIS-1 (n = 375) and AEGIS-2 (n = 130) clinical trials and gene expression profiled using microarrays. All statistical tests were two-sided. Results: We identified 535 genes that were differentially expressed in the nasal epithelium of AEGIS-1 patients diagnosed with lung cancer vs those with benign disease after one year of follow-up ( P < .001). Using bronchial gene expression data from the AEGIS-1 patients, we found statistically significant concordant cancer-associated gene expression alterations between the two airway sites ( P < .001). Differentially expressed genes in the nose were enriched for genes associated with the regulation of apoptosis and immune system signaling. A nasal lung cancer classifier derived in the AEGIS-1 cohort that combined clinical factors (age, smoking status, time since quit, mass size) and nasal gene expression (30 genes) had statistically significantly higher area under the curve (0.81; 95% confidence interval [CI] = 0.74 to 0.89, P = .01) and sensitivity (0.91; 95% CI = 0.81 to 0.97, P = .03) than a clinical-factor only model in independent samples from the AEGIS-2 cohort. Conclusions: These results support that the airway epithelial field of lung cancer-associated injury in ever smokers extends to the nose and demonstrates the potential of using nasal gene expression as a noninvasive biomarker for lung cancer detection.
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Thomas Blomquist; Erin L Crawford; D'Anna Mullins; Youngsook Yoon; Dawn-Alita Hernandez; Sadik Khuder; Patricia L Ruppel; Elizabeth Peters; David J Oldfield; Brad Austermiller; John C Anders; James C Willey Journal: Cancer Res Date: 2009-11-03 Impact factor: 12.701
Authors: Katrina Steiling; Maarten van den Berge; Kahkeshan Hijazi; Roberta Florido; Joshua Campbell; Gang Liu; Ji Xiao; Xiaohui Zhang; Grant Duclos; Eduard Drizik; Huiqing Si; Catalina Perdomo; Charles Dumont; Harvey O Coxson; Yuriy O Alekseyev; Don Sin; Peter Pare; James C Hogg; Annette McWilliams; Pieter S Hiemstra; Peter J Sterk; Wim Timens; Jeffrey T Chang; Paola Sebastiani; George T O'Connor; Andrea H Bild; Dirkje S Postma; Stephen Lam; Avrum Spira; Marc E Lenburg Journal: Am J Respir Crit Care Med Date: 2013-05-01 Impact factor: 21.405
Authors: David E Ost; Armin Ernst; Xiudong Lei; Kevin L Kovitz; Sadia Benzaquen; Javier Diaz-Mendoza; Sara Greenhill; Jennifer Toth; David Feller-Kopman; Jonathan Puchalski; Daniel Baram; Raj Karunakara; Carlos A Jimenez; Joshua J Filner; Rodolfo C Morice; George A Eapen; Gaetane C Michaud; Rosa M Estrada-Y-Martin; Samaan Rafeq; Horiana B Grosu; Cynthia Ray; Christopher R Gilbert; Lonny B Yarmus; Michael Simoff Journal: Am J Respir Crit Care Med Date: 2016-01-01 Impact factor: 21.405
Authors: Jennifer Beane; Paola Sebastiani; Theodore H Whitfield; Katrina Steiling; Yves-Martine Dumas; Marc E Lenburg; Avrum Spira Journal: Cancer Prev Res (Phila) Date: 2008-03-31
Authors: Duncan H Whitney; Michael R Elashoff; Kate Porta-Smith; Adam C Gower; Anil Vachani; J Scott Ferguson; Gerard A Silvestri; Jerome S Brody; Marc E Lenburg; Avrum Spira Journal: BMC Med Genomics Date: 2015-05-06 Impact factor: 3.063
Authors: Nichole T Tanner; Jyoti Aggarwal; Michael K Gould; Paul Kearney; Gregory Diette; Anil Vachani; Kenneth C Fang; Gerard A Silvestri Journal: Chest Date: 2015-12 Impact factor: 9.410
Authors: Yvonne Chang; Lisbeth K Siddens; Lauren K Heine; David A Sampson; Zhen Yu; Kay A Fischer; Christiane V Löhr; Susan C Tilton Journal: Toxicol Appl Pharmacol Date: 2019-06-27 Impact factor: 4.219
Authors: Linda L Garland; José Guillen-Rodriguez; Chiu-Hsieh Hsu; Lisa E Davis; Eva Szabo; Christopher R Husted; Hanqiao Liu; Ashley LeClerc; Yuriy O Alekseyev; Gang Liu; Julie E Bauman; Avrum E Spira; Jennifer Beane; Malgorzata Wojtowicz; H-H Sherry Chow Journal: Cancers (Basel) Date: 2022-06-11 Impact factor: 6.575
Authors: Linsey E Haswell; Sarah Corke; Ivan Verrastro; Andrew Baxter; Anisha Banerjee; Jason Adamson; Tomasz Jaunky; Christopher Proctor; Marianna Gaça; Emmanuel Minet Journal: Sci Rep Date: 2018-02-05 Impact factor: 4.379
Authors: Marc A Sala; Yalbi Itzel Balderas-Martínez; Ivette Buendía-Roldan; Hiam Abdala-Valencia; Kiwon Nam; Manu Jain; Sangeeta Bhorade; Ankit Bharat; Paul A Reyfman; Karen M Ridge; Annie Pardo; Jacob I Sznajder; G R Scott Budinger; Alexander V Misharin; Moises Selman Journal: Respir Res Date: 2018-11-26
Authors: Kenji Fujiyoshi; Yang Chen; Koichiro Haruki; Tomotaka Ugai; Junko Kishikawa; Tsuyoshi Hamada; Li Liu; Kota Arima; Jennifer Borowsky; Juha P Väyrynen; Melissa Zhao; Mai Chan Lau; Simeng Gu; Shanshan Shi; Naohiko Akimoto; Tyler S Twombly; David A Drew; Mingyang Song; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Reiko Nishihara; Jochen K Lennerz; Marios Giannakis; Jonathan A Nowak; Xuehong Zhang; Kana Wu; Shuji Ogino Journal: JNCI Cancer Spectr Date: 2020-05-14